Big pharma Merck, Bristol Myers, J&J prepare to lose revenue
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSE Big pharmaceutical companies such as Bristol Myers Squibb, Merck and Johnson & Johnson face a …
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSE Big pharmaceutical companies such as Bristol Myers Squibb, Merck and Johnson & Johnson face a …
Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Monday said its Covid vaccine sales plunged by about two-thirds in 2023 to $6.7 billion, as fewer people rolled up their …
CNBC’s Jim Cramer on Thursday gave his take on the worst performers in the Nasdaq-100 in 2023. Cramer compared each company’s closing price in 2022 to the end of 2023, …
My top 10 things to watch Thursday, Dec. 14 1. U.S. stocks are higher in premarket trading Thursday, with S & P 500 futures up 0.46%. Equities rallied Wednesday after …
CNBC’s Jim Cramer on Monday suggested that investors are not buying with a clear head and are choosing too many poorly-performing stocks. “I saw a hammered market, a market where …
My top 10 things to watch Friday, Dec. 1 1. U.S. stocks edge lower in premarket trading Friday, with S & P 500 futures down 0.2%. The move comes after …
Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Thursday posted a steep loss for the third quarter as the drugmaker recorded a large write-down due to unused Covid vaccines, …
CFOTO | Future Publishing | Getty Images Pfizer on Tuesday reported a narrower than expected loss for the third quarter as the drugmaker recorded charges largely related to struggles for …
For the first time in nearly two decades running JPMorgan Chase, CEO Jamie Dimon will voluntarily sell stock in the bank. The disclosure, in a securities filing Friday, detailed next …
Bristol Myers Squibb on Thursday reported quarterly adjusted earnings that topped expectations and posted revenue in line with estimates, even as sales of the company’s popular blood cancer drug Revlimid …